Benefits
ONLY Omega-3 Crossing Blood-Brain Barrier via Mfsd2a
Lysoveta is the only known omega-3 form proven to cross the blood-brain barrier through the Mfsd2a transporter — direct brain delivery of essential fatty acids.
Targeted Brain Omega-3 Delivery
Delivers essential omega-3 fatty acids DHA and EPA directly to the brain along with critical phospholipids and choline.
LPC-EPA Brain Conversion to DHA
Research indicates LPC-EPA is efficiently converted into DHA in the brain — enhancing brain DHA levels.
Brain Function and Cognitive Support
Supports brain function, cognitive performance, and overall brain health applications.
Patented Technology
Aker BioMarine's patented LPC extraction technology — proprietary breakthrough.
2025 CMA Innovation Award
Innovation Winner at 2025 Complementary Medicines Australia Industry Awards — industry recognition.
Choline + Phospholipid Delivery
Beyond omega-3, Lysoveta delivers choline and phospholipids — complete brain nutrition package.
Mechanism of action
Mfsd2a Transporter BBB Crossing
Mfsd2a (Major Facilitator Superfamily Domain Containing 2A) is specific transporter at blood-brain barrier for LPC-bound fatty acids; conventional triglyceride-bound omega-3s do NOT cross BBB efficiently via this route.
LPC vs Triglyceride Forms
Lysophosphatidylcholine (LPC) is phospholipid form with single fatty acid attached; uniquely transported across BBB; standard fish/krill oil omega-3s typically triglyceride-bound; do not access this transport pathway.
Brain DHA Synthesis from EPA
Once LPC-EPA crosses BBB, it can be converted to DHA in brain — addresses brain DHA needs even from EPA precursor.
Comprehensive Brain Nutrition
Delivers EPA, DHA, choline, phospholipids — all critical brain nutrients in one ingredient.
Clinical trials
Aker BioMarine clinical evaluation of Lysoveta LPC-bound omega-3 brain delivery and applications.
Adults across cognitive applications.
Established Mfsd2a-mediated BBB crossing; brain function applications.
About this ingredient
LYSOVETA is a BREAKTHROUGH BRAIN HEALTH INGREDIENT from AKER BIOMARINE — Norwegian biotechnology company; world's leading B2B krill oil supplier; pioneer of krill oil category.
KEY DISTINCTION: ONLY KNOWN OMEGA-3 FORM PROVEN TO CROSS BLOOD-BRAIN BARRIER via the Mfsd2a transporter — patented technology. LYSOPHOSPHATIDYLCHOLINE (LPC) BACKGROUND: phospholipid with single fatty acid attached; precursor to cell membrane structures; uniquely transported across BBB via Mfsd2a; conventional fish oil/krill oil omega-3s in triglyceride form do NOT efficiently access this BBB transport.
KEY DISTINCTIONS: (1) ONLY OMEGA-3 with proven Mfsd2a BBB transport; (2) PATENTED Aker BioMarine technology; (3) LPC-BOUND EPA AND DHA for direct brain delivery; (4) Choline and phospholipids included; (5) 2025 CMA Innovation Award; (6) Krill source — sustainable Antarctic fishery; (7) MSC and Friends of the Sea certified; (8) Aker BioMarine quality and global supply.
EVIDENCE-BASED USES: (1) Brain health and cognitive function; (2) Direct BBB omega-3 delivery; (3) Brain DHA support (via LPC-EPA conversion); (4) Comprehensive brain nutrition (omega-3 + choline + phospholipids); (5) Neurological applications.
CRITICAL CAUTIONS: (1) SHELLFISH ALLERGY — krill is crustacean; may cross-react with shellfish allergies; AVOID with shellfish allergy; (2) DOSE — per Aker BioMarine specification; (3) PREGNANCY — limited specific Lysoveta data; krill omega-3 generally considered safe; consult; (4) PRE-SURGERY — discontinue 1-2 weeks; (5) ANTICOAGULANTS — modest effects; (6) LYSOVETA vs FISH OIL — fish oil triglyceride-bound omega-3 less efficient at BBB; Lysoveta LPC form uniquely brain-targeted; (7) LYSOVETA vs SUPERBA KRILL — same Aker BioMarine company; Superba phospholipid omega-3 for general health; LYSOVETA specifically LPC-bound for brain targeting; complementary; (8) LYSOVETA vs ALGAE DHA — both alternative to fish oil; LYSOVETA uniquely brain-targeted; algae for direct DHA needs; (9) LYSOVETA vs CURQFEN (Akay) — different mechanism for BBB crossing; CurQfen via FenuMat technology for curcumin; LYSOVETA via Mfsd2a transporter for omega-3; both brain-targeted ingredients; (10) FOR COMPREHENSIVE BRAIN HEALTH — sleep, exercise, cognitive engagement, social connection, omega-3, possibly nootropics, supplements adjunct; (11) BRAND VERIFICATION — Lysoveta is Aker BioMarine trademark; specific patented LPC technology; (12) Among the most innovative brain-targeted nutrient delivery technologies.